Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...

Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive results across all three Phase 3 TEMPO trials ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

Parkinson’s symptoms develop slowly, most commonly after the age of 50, and include tremor, slowness in movement, limb stiffness, problems with gait and balance, sleep disorders, and mental health ...

Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people ...

Scientists have developed a groundbreaking technique enabling them to visualise tiny brain clusters believed to trigger Parkinson’s disease. Researchers hailed the breakthrough, likening it to "being ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...

Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide. Published in the Journal of Neuroscience, new research from the ...

A computer illustration of human pegivirus, an RNA (ribonucleic acid) virus scientists believe may be linked to Parkinson's disease. Illustration by Kateryna Kon, Science Photo Library More than 10 ...

Share on Pinterest Scientists have developed a weekly injectable treatment for Parkinson’s disease. Chalit Saphaphak/Stocksy Parkinson’s symptoms develop slowly, most commonly after the age of 50, and ...